Variational AI

Vancouver startup using generative AI to design new drug molecules, working with partners including Merck.

Vancouver Generative AI for small-molecule drug discovery.

Variational AI is a Vancouver company, founded in 2019, that uses generative AI to design new small-molecule drugs. Its Enki platform generates novel, optimized molecules for a given target, with the aim of cutting early drug discovery from years to months.

The company has a collaboration with Merck and, in 2026, received provincial health testbed funding with 3C Therapeutics to apply its platform to cancer treatments.

Reviews · Verified with LinkedIn

Worked with Variational AI?

Reviews are coming to 604list. Every review will be tied to a real LinkedIn profile, so you know the person behind it exists. No anonymous reviews, and no business owners reviewing themselves.

No reviews yet.

Reviews will show the reviewer's name, title and company from LinkedIn, plus the date and what they hired Variational AI for.

Message Variational AI